DNB CTVS Question- December 2013

DECEMBER 2013  

PAPER II
1. a. Enumerate causes of pleural effusion. b. mention the criteria to label an effusion as a transudate or exudates. c. Management of malignant pleural effusion.3+3+ 4
2. a. Enumerate names of 6 trials comparing CABG with PCI.    b. What is MACE?   c. What are the recent outcomes from the syntax trial? 3+2+ 5
3. a. Describe the blood supply of the spinal cord.   b. Classify thoraco-abdominal aneurysms with diagram(s).   c. Describe landing zone criteria.4+3+ 3
4. a. What are modified Duke’s criteria for diagnosing native valve  endocarditis (NVE)?    b. Enumerate the organisms responsible for NVE.    c. What is the guideline for surgery in NVE? 4+2+4
5. a. Enumerate the congenital coronary artery anomalies.    b. What are the different options available for treating ALCAPA?5+ 5
6. a. What are the Choussat’s criteria for single ventricle repair? b. Describe the concept of one and a half ventricle repair? Where is it  indicated?  c. Enumerate complications of single ventricle repair.4+3+ 3
7. a. Enumerate complications of MI.  b. Briefly describe the surgical management of post MI VSD. 5+5
8. a. What do you mean by [i] bridge to transplant                                                  [ii]destination therapy       [iii] bridge to recovery? 6
b. What are the different types of long term mechanical circulatory support         devices? Briefly discuss its follow up. 4
9. a. What is post-operative renal dysfunction?  b. Mention its etiology and     diagnosis.  c. Briefly describe management of this disorder.2+(2+2)+ 4
10. a. Enumerate the PDA dependent circulation. b. How will you maintain patency of the PDA in such a case and mention complications of such therapy?     c. What is differential  cyanosis and mention its causes? 2+5+3

DECEMBER 2013  PAPER III
1. a. Describe the applied anatomy of mitral valve. b. What are the surgical methods to tackle ischemic mitral regurgitation? [5+5]
2. Discuss lung transplant under the following headings:
a. Indications [4]
b. Post operative complications [4]
c. Results [2]
3. a. What is PET? [1]
b. What is its role in SOL of lung? [4]
c. What is its role in ischaemic myocardium and ischaemic    cardiomyopathy? [5]
4. A) what is lung volume reduction Surgery (LVRS)
B)mention inclusion and exclusion criterion
C) Mention surgical techniques 1+3+3+1
5. A) state the materials used in making bio-valves and outline the treatment procedures available
B) Discuss the current status of bioprosthetic valve uses  5+5
6. A) what is patient prosthetic mismatch (PPM)
B) classify PPM
C) how do you investigate a patient suspected to have severe PPM  3+2+5
7. A) What is cardiac MRI
B) explain its relevance in defining anatomy , physiology, and function of heart with examples 2+3+3+2
8. A) Discuss intraoperative graft patency assessment during CABG
B) Discuss briefly background and current status of TMR ( TRANS MYOCARDIAL REVASCULARIZATION). 5+5
9. Describe the pathogenesis , causes and management of pulmonary hypertensive crisis. 3+2+5
10. A) Discuss the immunopathology of myasthania gravis
B) Discuss the biological markers in carcinoma lung. 5+5

Author: what2talk

Myself, Dr. Sibashankar Kar, doing my Cardiothoracic Surgery in Sir Ganga Ram Hospital. The purpose I have made this website is to discuss on the topics of cardiology and cardiac surgery as a whole with their complexities.

Leave a Reply